Arthritis Research & Therapy

official impact factor 4.36

This article is part of the supplement: Gastroprotection: the role of proton pump inhibitors

Highly Access

Practical approaches to minimizing gastrointestinal and cardiovascular safety concerns with COX-2 inhibitors and NSAIDs

James M Scheiman* and A Mark Fendrick

Arthritis Research & Therapy 2005, 7(Suppl 4):S23-S29 doi:10.1186/ar1795

Accesses  

  • Last 30 days: 58 accesses
  • Last 365 days: 618 accesses
  • All time: 6616 accesses

Cited by

BioMed Central: 1 citation

Review   Open Access Highly Accessed

A review of the benefits and risks of nonsteroidal anti-inflammatory drugs in the management of mild-to-moderate osteoarthritis

A Mark Fendrick, Bruce P Greenberg Osteopathic Medicine and Primary Care 2009, 3:1 (6 January 2009)